Kezar Life Sciences
在场
高管
查看带有其 23 名主要高管的组织结构图
Kezar Life Sciences 搜索最多的简介
- Christopher Kirk, Director and Chief Executive Officer
- Elizabeth Garner, Director
- Micki Klearman, Director
高管在Kezar Life Sciences变化
- Christopher Kirk 曾任 Director, President and Chief Scientific Officer, 将于 202311月3 升职为 Director and Chief Executive Officer (新闻发布的2023十月4号).
创建提醒
跟踪 Kezar Life Sciences 的高管变动
生物技术
Kezar Life Sciences 拥有 2,291 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Deepull (西班牙)。
Popular M&A news in 生物技术
- Rapport Therapeutics 刚刚宣布为 154 筹款数百万美元。 (公布2024六月11号).
- Amber Therapeutics 刚刚宣布为 100 筹款数百万美元。 (公布2024六月10号).
- Restor3d 刚刚宣布为 70 筹款数百万美元。 (公布2024六月8号).
生物技术 行业的其他推荐联系人
消息
Kezar Life Sciences 的最新新闻稿
- Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference | Kezar Life Sciences, Inc.
- Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Kezar Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
- Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Kezar Announces Topline Results from PRESIDIO Trial of Zetomipzomib for the Treatment of Dermatomyositis and Polymyositis
- Kezar Life Sciences to Participate in Two Upcoming Investor Conferences :: Kezar Life Sciences, Inc. (KZR)
- Kezar Life Sciences Announces Completion of Enrollment of Its Phase 2 PRESIDIO Clinical Trial of KZR-616 in Polymyositis and Dermatomyositis :: Kezar Life Sciences, Inc. (KZR)
- Kezar Life Sciences Reports Second Quarter Financial Results and Provides Business Updates :: Kezar Life Sciences, Inc. (KZR)
- Kezar Life Sciences to Participate in the William Blair Biotech Focus Conference 2021 :: Kezar Life Sciences, Inc. (KZR)
- Kezar Life Sciences Announces Formation of Clinical Advisory Committee :: Kezar Life Sciences, Inc. (KZR)
- View more press releases Close
通过电子邮件
